GRAIL, Inc.
GRALNasdaq
$72.62
↑ +0.9%Jul 17 close · end-of-day
Price
1Y↑ +98.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$3.0B
Enterprise Value
$2.9B
P/E
—
P/S
18.9
P/B
1.2
EV/EBITDA
—
PEG
—
FCF Yield
-9.9%
Dividend Yield
—
Revenue (TTM)
$156.1M
Net Income (TTM)
-$395.3M
Free Cash Flow (TTM)
-$292.3M
Gross Margin
—
Operating Margin
-348.7%
Net Margin
—
ROE
—
ROIC
-17.7%
Debt / Equity
—
Net Cash
$69.3M
Return 1Y
+102.2%
Company profile
GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. GRAIL, LLC was formerly known as PSC15, Inc. and changed its name to GRAIL, LLC in January 2016. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, LLC operates as a subsidiary of Illumina, Inc.
- CEO
- Joshua J. Ofman
- Sector
- Services
- Industry
- Healthcare
- Headquarters
- California
- Website
- grail.com
Management & directors
- Partridge Andrew JohnChief Growth Officer
- Ofman Joshua J.Chief Executive Officer
- Freidin AaronChief Financial Officer
- Ragusa Robert PChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
GRAL Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$40.8M↑ +28.1%
Diluted EPS-$2.29↓ -26.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $55.5M | $93.1M | $125.6M | $147.2M |
| Gross profit | — | — | — | — |
| Operating income | -$5.4B | -$1.5B | -$2.2B | -$562.2M |
| Net income | -$5.4B | -$1.5B | -$2.0B | -$408.4M |
| Diluted EPS | -$173.89 | -$47.21 | -$63.54 | -$11.11 |
| Operating cash flow | -$561.3M | -$595.8M | -$577.2M | -$299.0M |
| Free cash flow | -$584.2M | -$608.7M | -$582.4M | -$299.9M |
| Gross margin | — | — | — | — |
| Operating margin | -9798.2% | -1627.6% | -1743.0% | -382.0% |
| Net margin | -9719.3% | -1574.2% | -1613.9% | -277.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $32.0M | $28.7M | $38.3M | $31.8M | $35.5M | $36.2M | $43.6M | $40.8M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$1.6B | -$183.5M | -$136.9M | -$153.6M | -$158.9M | -$125.3M | -$124.4M | -$135.8M |
| Net income | -$1.6B | -$125.7M | -$97.1M | -$106.2M | -$114.0M | -$89.0M | -$99.2M | -$93.2M |
| Diluted EPS | -$51.06 | -$3.94 | -$1.49 | -$3.10 | -$3.18 | -$2.46 | -$2.37 | -$2.29 |
| Operating cash flow | -$171.8M | -$104.6M | -$93.5M | -$95.0M | -$77.0M | -$63.2M | -$63.8M | -$87.0M |
| Free cash flow | -$173.2M | -$105.6M | -$93.8M | -$95.1M | -$77.3M | -$63.6M | -$63.9M | -$87.5M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -5133.8% | -640.5% | -358.0% | -482.5% | -446.9% | -346.2% | -285.4% | -332.9% |
| Net margin | -4958.8% | -438.7% | -253.8% | -333.6% | -320.7% | -245.8% | -227.5% | -228.5% |
Company news
Jun 25, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | SUMME GREGORY L | Award | 427 | $74.36 | $31,751.72 | filing |
| 2026-07-15 | CHASE WILLIAM J | Award | 276 | $74.36 | $20,523.36 | filing |
| 2026-07-15 | MIZELL STEVEN | Award | 268 | $74.36 | $19,928.48 | filing |
| 2026-06-18 | Krevans Sarah | Award | 5,491 | $63.74 | $349,996.34 | filing |
| 2026-06-18 | CHASE WILLIAM J | Award | 5,491 | $63.74 | $349,996.34 | filing |
| 2026-06-18 | MIZELL STEVEN | Award | 5,491 | $63.74 | $349,996.34 | filing |
| 2026-06-18 | SUMME GREGORY L | Award | 5,491 | $63.74 | $349,996.34 | filing |
| 2026-06-04 | Partridge Andrew John· Chief Growth Officer | Sale | 1,491 | $61.08 | $91,070.28 | filing |
| 2026-06-03 | Ofman Joshua J.· Chief Executive Officer | Award | 3,154 | $61.13 | $192,804.02 | filing |
| 2026-06-01 | Ofman Joshua J.· Chief Executive Officer | Award | 27,901 | $64.40 | $1.8M | filing |
| 2026-04-15 | SUMME GREGORY L | Award | 631 | $49.79 | $31,417.49 | filing |
| 2026-04-15 | CHASE WILLIAM J | Award | 408 | $49.79 | $20,314.32 | filing |
| 2026-04-15 | MIZELL STEVEN | Award | 396 | $49.79 | $19,716.84 | filing |
| 2026-04-08 | RAGUSA ROBERT P· Chief Executive Officer | Sale | 123,502 | $49.92 | $6.2M | filing |
| 2026-04-08 | Ofman Joshua J.· President | Sale | 61,665 | $49.92 | $3.1M | filing |
| 2026-04-08 | Freidin Aaron· Chief Financial Officer | Sale | 45,806 | $49.92 | $2.3M | filing |
| 2026-03-09 | RAGUSA ROBERT P· Chief Executive Officer | Sale | 7,203 | $47.93 | $345,239.79 | filing |
| 2026-03-09 | Ofman Joshua J.· President | Sale | 2,836 | $47.93 | $135,929.48 | filing |
| 2026-03-09 | Freidin Aaron· Chief Financial Officer | Sale | 2,407 | $47.93 | $115,367.51 | filing |
| 2026-03-09 | RAGUSA ROBERT P· Chief Executive Officer | Sale | 258 | $46.73 | $12,056.34 | filing |
| 2026-03-09 | Ofman Joshua J.· President | Sale | 101 | $46.74 | $4,720.74 | filing |
| 2026-03-09 | Freidin Aaron· Chief Financial Officer | Sale | 85 | $46.74 | $3,972.90 | filing |
| 2026-03-05 | RAGUSA ROBERT P· Chief Executive Officer | Sale | 980 | $53.01 | $51,949.80 | filing |
| 2026-03-05 | Ofman Joshua J.· President | Sale | 690 | $53.01 | $36,576.90 | filing |
| 2026-03-05 | Freidin Aaron· Chief Financial Officer | Sale | 655 | $53.01 | $34,721.55 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.